Alpine Global Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Alpine Global Management's VRTX Position: Q3 2023 in Review

Alpine Global Management sold out of Vertex Pharmaceuticals (VRTX) in Q3 2023, closing a stake of 9,375 shares — an estimated $3.3M sold.

Alpine Global Management first reported a position in VRTX in Q4 2014 and held it in 4 quarters. The position peaked at $3.3M in Q2 2023. 1,277 funds tracked by Wall St. Rank hold VRTX as of Q3 2023.

• Alpine Global Management reported no remaining Vertex Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
• Alpine Global Management sold 9,375 Vertex Pharmaceuticals shares in Q3 2023, an estimated $3.3M.
• Alpine Global Management first reported a position in Vertex Pharmaceuticals in Q4 2014 and held it in 4 quarters.
• Alpine Global Management's Vertex Pharmaceuticals position peaked at $3.3M in Q2 2023.
• 1,277 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2023.

Based on Alpine Global Management's 13F filing for Q3 2023, filed 14 Nov 2023.